EUCTR2011-001956-12-CZ进行中（未招募）1 期
Monitoring of MxA mRNA Expression as a Marker of Rresponse to Interferon ß Therapy in Patients with Multiple Sclerosis.
niversity Hospital Motol0 个研究点目标入组 85 人开始时间: 2011年5月4日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 85
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Male and female 18-55 years old
- •Diagnosis of multiple sclerosis established with Mc Donald criteria(2005) or clinically isolated syndrom suspected of the next MS development.
- •Patients starting IFNß treatment
- •Effective contraception in male and in female patients of childbearing potential has been introduced.
- •Willingness to accept the plan of the study and compliance with the study.
- •No active major organ disease especially of hepatic or thyroid origin.
- •Patient has given written informed consent to participate in the study.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 85
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Age less than 18 or more than 55.
- •Noneffective contraception method or pregnancy planning.
- •Active major organ disease, especially hepatic or endocrinologic.
- •Cooperation of the subject cannot be ensured.
- •History of alcohol or drug abuse within 2 years prior to study entry.
- •Severe depression
研究者
相似试验
尚未招募
不适用
Patients with SARSCOV-2 with its mRNA levels of Blimp1 alpha and betaCTRI/2020/12/029868SN Medical college
进行中（未招募）
1 期
Assessment of the possible protective effect of anesthetics on the heart in patients undergoing cardiac surgery.Cardiac surgeryEUCTR2016-003413-10-ESFIMABIS
Unknown
4 期
mRNA Expression as a Biomarker of Omalizumab ResponseAsthmaNCT01584687Instituto de Investigação em Imunologia6
已完成
不适用
Validation of a miRNA biomarker signature for early detection of lung cancer.C34.1Upper lobe, bronchus or lungDRKS00031791Hummingbird Diagnostics359
招募中
不适用
microRNA as prognostic and diagnostic markers in malignant melanoma.C43.9Malignant melanoma of skin, unspecifiedDRKS00024417niversitätsklinikum Halle (Saale)10